Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.55 |
| ▸ | NPC1 | O15118 | 4/20 | 0.55 |
| ▸ | RAB9A | P51151 | 4/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | PPARG | P37231 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4102084 | 0.85 | SMPD1 (0.51) | L3MBTL1NPC1SMN1; SMN2TDP1MAPT | |
| SCHEMBL4102102 | 0.84 | GSTP1 (0.54) | L3MBTL1NPC1RAB9ASMN1; SMN2TDP1 | |
| SCHEMBL4098151 | 0.84 | PPARA (0.50) | NPC1RAB9ATDP1MAPTPOLB | |
| SCHEMBL4107394 | 0.82 | PPARG (0.63) | L3MBTL1NPC1TDP1POLBPPARG | |
| SCHEMBL14269429 | 0.81 | RAB9A (0.63) | L3MBTL1NPC1RAB9ASMN1; SMN2TDP1 | |
| SCHEMBL4096147 | 0.80 | PPARG (0.49) | NPC1MAPTPOLBPPARG | |
| SCHEMBL4108188 | 0.79 | PPARG (0.51) | NPC1POLBPPARG | |
| SCHEMBL4103807 | 0.79 | PPARA (0.58) | MAPTPOLBPPARG | |
| SCHEMBL4097643 | 0.78 | PPARG (0.57) | L3MBTL1NPC1SMN1; SMN2TDP1POLB | |
| SCHEMBL4098899 | 0.78 | PPARG (0.54) | NPC1RAB9ASMN1; SMN2TDP1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090054435-A1 | Phenoxyalkanoic Acid Compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-1911738-A1 | PHENOXYALKANOIC ACID COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2008-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054435-A1 | Phenoxyalkanoic Acid Compound | PNLIP, GPR119, LIPC | L3MBTL1 1870/4885NPC1 170/4885RAB9A 4163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.